Five high-impact drugs coming soon
View the latest OptumRx Drug Pipeline Insights Report
At OptumRx, we are committed to providing up-to-date information and support regarding drug access, cost management and notable FDA approvals.
While COVID-19 and associated vaccines continue to dominate the news, the broader drug pipeline remains robust. We anticipate that in 2021 the number of novel FDA approvals could approach a new record high.
See the five high-impact drugs expected to come to market this spring and significantly impact a range of conditions.
Don't want to read the full report? Download the brief summary.